MTD successfully completes acquisition of Pen Needles and Blood Glucose Monitoring Systems business units of Ypsomed
Acquiring Company
MTD Group
Acquired Company
Ypsomed
BurgdorfManufacturingBiotechnologyHealth CareMedicalMedical DeviceManufacturingBiotechnologyDescription
MTD announces the successful completion of the strategic acquisition of Pen Needles and Blood Glucose Monitoring Systems (BGM) business units from Ypsomed. This acquisition strengthens MTD's position as the clear number two in the world market for pen needles, expands its product portfolio, and facilitates entry into high-growth markets like China and India.
Quick answer
MTD Group is acquiring Ypsomed, announced August 2, 2024.
- How much did MTD Group pay for Ypsomed?
- The deal value was not disclosed.
- What does MTD Group do?
- Medical Technology and Devices (MTD) is a consumer health group owning a portfolio of global brands with leading position across Diabetes, Medical Sharps, Wound Care, Heart Monitors, Thermometers & Nebulizers.
- Where are MTD Group and Ypsomed based?
- Ypsomed is based in Burgdorf, Bern, Switzerland.
Source: Fundz verified event record.
Other recent acquisitions in Medical and Medical Device
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- AA Medical completes acquisition of Surgical Product Solutions, forming strategic partnership (July 11, 2024)
- Edwards Lifesciences Completes Acquisitions of JenaValve Technology and Endotronix (July 24, 2024)
- KARL STORZ completes acquisition of Asensus Surgical, Inc. to strengthen its position in robotic and digital surgical market (August 22, 2024)
- GE HealthCare to acquire clinical artificial intelligence business from Intelligent Ultrasound Group PLC (July 18, 2024)
- Becton, Dickinson and Company (BDX) completes acquisition of Critical Care from Edwards Lifesciences (September 3, 2024)
- BD completes acquisition of Edwards Lifesciences' Critical Care product group to expand its smart connected care solutions portfolio (September 3, 2024)
Who to call at MTD Group, and when
When MTD Group changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day MTD Group raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at MTD Group, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at MTD Group. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment MTD Group makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Ypsomed?
Ypsomed was acquired by MTD Group. The deal was reported on August 2, 2024. Medical Technology and Devices (MTD) is a consumer health group owning a portfolio of global brands with leading position across Diabetes, Medical Sharps, Wound Care, Heart Monitors, Thermometers & Nebulizers. MTD Group is privately held and operates in Manufacturing.
When did MTD Group acquire Ypsomed?
MTD Group's acquisition of Ypsomed was reported on August 2, 2024. MTD announces the successful completion of the strategic acquisition of Pen Needles and Blood Glucose Monitoring Systems (BGM) business units from Ypsomed. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Ypsomed do?
Ypsomed is the leading developer and manufacturer of injection and infusion systems for self-medication and a renowned diabetes specialist. The company will celebrate its 40th anniversary in 2024. It is privately held, operating in Manufacturing, and is based in Burgdorf.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.